News

In part 2 of “This Wasn't the Plan,” a young woman recalls her stage 4 blood cancer diagnosis and how chemotherapy revealed ...
Bemarituzumab targets FGFR2b, which has been found to be overexpressed in approximately 30% of patients with non-HER2 positive gastric cancer.
During a live event, Neal E. Ready, MD, and participants discussed what factors justify using PD-1 plus CTLA-4 inhibitor and ...
In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...
Amgen said a Phase 3 trial of its gastric cancer treatment, bemarituzumab, met its primary endpoint of overall survival at a pre-specified interim analysis.
After six cycles of chemotherapy, Cesca Litton is finally done and is looking forward to her next battle with breast cancer.
Exclusive: Former sales director Joseph DeRosa, who has a Body Mass Index of 43, claims his manager relentlessly fat-shamed ...
Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...
A Ukrainian woman, Olha Kurtmalaieva, has endured cancer and war while fighting to bring her husband home from Russian ...
TV host Cesca Litton celebrates her "win" after finishing six cycles of chemotherapy. The TV host opened up about her breast ...
Omaha nonprofit goes on its eighth year of packing and distributing care packages for breast cancer survivors.
Test, developed by University of Cambridge, looks at structure of tumour DNA and forecasts whether it will resist treatment ...